These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
121 related articles for article (PubMed ID: 32839593)
1. The unequal scramble for coronavirus vaccines - by the numbers. Callaway E Nature; 2020 Aug; 584(7822):506-507. PubMed ID: 32839593 [No Abstract] [Full Text] [Related]
2. If a coronavirus vaccine arrives, can the world make enough? Khamsi R Nature; 2020 Apr; 580(7805):578-580. PubMed ID: 32273621 [No Abstract] [Full Text] [Related]
3. India will supply coronavirus vaccines to the world - will its people benefit? Vaidyanathan G Nature; 2020 Sep; 585(7824):167-168. PubMed ID: 32884143 [No Abstract] [Full Text] [Related]
4. Legal agreements: barriers and enablers to global equitable COVID-19 vaccine access. Phelan AL; Eccleston-Turner M; Rourke M; Maleche A; Wang C Lancet; 2020 Sep; 396(10254):800-802. PubMed ID: 32910908 [No Abstract] [Full Text] [Related]
5. The costs of coronavirus vaccines and their pricing. Light DW; Lexchin J J R Soc Med; 2021 Nov; 114(11):502-504. PubMed ID: 34732097 [No Abstract] [Full Text] [Related]
6. Omicron is bad but the global response is worse. Nature; 2021 Dec; 600(7888):190. PubMed ID: 34876667 [No Abstract] [Full Text] [Related]
7. Global access to insulin. Holt RIG Diabet Med; 2019 Jun; 36(6):663-664. PubMed ID: 31074546 [No Abstract] [Full Text] [Related]
8. The fight to manufacture COVID vaccines in lower-income countries. Maxmen A Nature; 2021 Sep; 597(7877):455-457. PubMed ID: 34526695 [No Abstract] [Full Text] [Related]
9. [Vaccines: from seed virus to approval]. Bruhn C Dtsch Med Wochenschr; 2009 Nov; 134(48):p44. PubMed ID: 19941270 [No Abstract] [Full Text] [Related]
10. [TBE vaccines--safety and efficiency at any cost]. Wahlberg T Lakartidningen; 1999 Mar; 96(12):1425. PubMed ID: 10222700 [No Abstract] [Full Text] [Related]
11. Profile. Dollars and cents vs. the AIDS epidemic. Vogel G Science; 2001 Jun; 292(5526):2420-2. PubMed ID: 11431547 [No Abstract] [Full Text] [Related]
12. COVID-19 vaccine affordability and accessibility. Karim SA Lancet; 2020 Jul; 396(10246):238. PubMed ID: 32711799 [No Abstract] [Full Text] [Related]
13. An industry update: the latest developments in therapeutic delivery covering May 2020. Steinbach OC Ther Deliv; 2020 Sep; 11(9):541-546. PubMed ID: 32840177 [TBL] [Abstract][Full Text] [Related]
14. FDA chief wants other rich countries to share drug development costs. Hopkins Tanne J BMJ; 2003 Oct; 327(7419):830. PubMed ID: 14551076 [No Abstract] [Full Text] [Related]
15. Unequal access to vaccines in the WHO European Region during the A(H1N1) influenza pandemic in 2009. Jorgensen P; Wasley A; Mereckiene J; Cotter S; Weber JT; Brown CS Vaccine; 2013 Aug; 31(38):4060-2. PubMed ID: 23845820 [TBL] [Abstract][Full Text] [Related]
16. Back to the future. Offit P Expert Rev Vaccines; 2004 Apr; 3(2):107-8. PubMed ID: 15056035 [No Abstract] [Full Text] [Related]
17. Licensing IP to ensure accessibility to vaccines and other immunisation-related products. Mehta JM Vaccine; 2001 Feb; 19(13-14):1581-7; discussion 1592-3. PubMed ID: 11166878 [No Abstract] [Full Text] [Related]
18. Unequal Access to Vaccines Will Exacerbate Other Inequalities. Cheong MWL; Allotey P; Reidpath DD Asia Pac J Public Health; 2020; 32(6-7):379-380. PubMed ID: 32715721 [No Abstract] [Full Text] [Related]